CALA - カリセラ・バイオサイエンシズ （Calithera Biosciences Inc.） カリセラ・バイオサイエンシズCALAのチャート
CALAの企業情報
| symbol | CALA |
|---|---|
| 会社名 | Calithera Biosciences Inc. （カリセラ・バイオサイエンシズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 ケリセラ・バイオサイエンス（Calithera Biosciences Inc.）は、臨床段階の製薬会社である。同社は、腫瘍微小環境における重要な代謝経路を制御する腫瘍及び免疫細胞標的に対する低分子薬物の発見及び開発に焦点を当てる。同社は、細胞傷害性T細胞のような腫瘍細胞及びガンと戦う免疫細胞の代謝要求を利用する薬剤の開発に従事する。同社のリード製品候補であるCB-839は、腫瘍細胞における重要な酵素である。CB-1158は、血液学及び腫瘍学の適応症のために開発される。CB-1158は、酵素アルギナーゼの強力かつ選択的な経口生物学的利用可能阻害剤である。CB-839は、ヒトグルタミナーゼの選択的で可逆的かつ経口的に生体利用可能な阻害剤である。CB-1158は、免疫機構を介して作用することが実証されている同系マウス腫瘍モデルにおいて、単剤抗腫瘍活性を有する。CB-1158は、固形腫瘍患者の第I相臨床試験で試験される。 カリセラ・バイオサイエンシズは米国の臨床段階の医薬品会社。主に、がんの治療のために腫瘍代謝及び腫瘍免疫学を対象に低分子薬剤の発見・開発に重点を置く。製品候補には、腫瘍代謝において重要な酵素であるグルタミナ―ゼ抑制剤「CB-839」、そして、アルギナ―ゼ抑制剤などがある。本社はカリフォルニア州。 calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells. calithera’s discovery and development efforts are focused on solid tumors for which new treatments are urgently needed. we are currently developing our lead candidate in phase 2 trials in patients with renal cell carcinoma, triple negative breast cancer. targeting cancer, differently. our onco-metabolism approach brings an enhanced perspective to cancer. |
| 本社所在地 | 343 Oyster Point Blvd. Suite 200 South San Francisco CA 94080 USA |
| 代表者氏名 | Susan M. Molineaux スーザンM.モリノー |
| 代表者役職名 | President Chief Executive Officer Co-Founder Director |
| 電話番号 | +1 650-870-1000 |
| 設立年月日 | 40238 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2014年 |
| 従業員数 | 73人 |
| url | www.calithera.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cala |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -35.29600 |
| 終値（lastsale） | 5.46 |
| 時価総額（marketcap） | 196491089.34 |
| 時価総額 | 時価総額（百万ドル） 197.57070 |
| 売上高 | 売上高（百万ドル） 36.76200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 56.15670 |
| 当期純利益 | 当期純利益（百万ドル） -33.32600 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Calithera Biosciences Inc revenues increased 94% to $22.3M. Net loss increased 51% to $16.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other Research and Development increase of 100% to $30.9M (expense) Stock-based Compensation in SGA increase of 63% to $1.9M (expense). |
CALAのテクニカル分析
CALAのニュース
Calithera Biosciences plans special meeting to seek approval for liquidation and dissolution plan 2023/05/19 20:53:27 Seeking Alpha
Calithera Biosciences (CALA) plans to hold a special meeting of stockholders around June 29, to seek approval for its Plan of Complete Liquidation and Dissolution.The company announced…
kölbi Negocios Leverages Ribbon Connect to Seamlessly Deliver Microsoft Teams Phone Capabilities for Business Customers 2023/04/24 12:00:00 Kwhen Finance
Nasdaq to delist shares of Waitr and Calithera Biosciences, among others 2023/03/01 23:21:09 Seeking Alpha
Nasdaq said Wednesday it will delist shares of Waitr (ASAP), Calithera Biosciences (CALA), Statera Biopharma (STAB), Allied Healthcare Products (AHPI) and Tricida (TCDAQ).The exchange…
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta 2023/03/01 21:05:00 Wallstreet:Online
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Scopus BioPharma Inc. Scopus BioPharma Inc. common stock was
PRIMECAP Management''s Top 5 Sells of the 4th Quarter 2023/02/13 20:00:04 GuruFocus
Check out PRIMECAP Management Stock Picks » Download GuruFolio Report of PRIMECAP Management (Updated on 02/12/2023) Related Stocks: CALA , LLY , ABMD , MSFT , SCHW ,
Nasdaq to delist shares of Waitr and Calithera Biosciences, among others 2023/03/01 23:21:09 Seeking Alpha
Nasdaq said Wednesday it will delist shares of Waitr (ASAP), Calithera Biosciences (CALA), Statera Biopharma (STAB), Allied Healthcare Products (AHPI) and Tricida (TCDAQ).The exchange…
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta 2023/03/01 21:05:00 Wallstreet:Online
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on November 30, 2022, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Scopus BioPharma Inc. Scopus BioPharma Inc. common stock was
PRIMECAP Management''s Top 5 Sells of the 4th Quarter 2023/02/13 20:00:04 GuruFocus
Check out PRIMECAP Management Stock Picks » Download GuruFolio Report of PRIMECAP Management (Updated on 02/12/2023) Related Stocks: CALA , LLY , ABMD , MSFT , SCHW ,
Surprising stocks: Cosmos Holdings Inc. (NASDAQ:COSM -5.84%), Calithera Biosciences, Inc. (NASDAQ:CALA -40.03%) 2023/02/08 11:46:12 Stock Equity
COSM has seen its SMA50 which is now -34.26%. In looking the SMA 200 we see that the stock has seen a -52.66%. CALA has seen its SMA50 which is … The post Surprising stocks: Cosmos Holdings Inc. (NASDAQ:COSM -5.84%), Calithera Biosciences, Inc. (NASDAQ:CALA -40.03%) appeared first on Stocks Equity .
Bewitching stocks: Genius Brands International, Inc. (NASDAQ:GNUS 0.06%), Calithera Biosciences, Inc. (NASDAQ:CALA 5.24%) 2023/01/30 17:48:42 Stock Equity
GNUS has seen its SMA50 which is now 5.81%. In looking the SMA 200 we see that the stock has seen a -4.18%. CALA has seen its SMA50 which is … The post Bewitching stocks: Genius Brands International, Inc. (NASDAQ:GNUS 0.06%), Calithera Biosciences, Inc. (NASDAQ:CALA 5.24%) appeared first on Stocks Equity .
Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 2021/07/29 11:00:00 Intrado Digital Media
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a fully-integrated clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Companys second quarter 2021 financial results will be released on Thursday, August 5, 2021. Company management will host a conference call on Thursday, August 5, 2021 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
Waldenstrom Macroglobulinemia Therapeutics Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: BeiGene(Beijing) Co.,Ltd, Calithera Biosciences, Inc., Celgene Co 2021/07/25 23:28:18 Jumbo News
The documented report on Global Waldenstrom Macroglobulinemia Therapeutics Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or []
Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA) 2021/07/20 22:29:42 Stock Equity
Exxon Mobil Corporation (NYSE:XOM) with the stream of 1.19% also noticed, India Calithera Biosciences, Inc. (NASDAQ:CALA) encountered a rapid change of 2.78% in the last hour of Tuesdays trading session. The post Early Moves to Watch: Exxon Mobil Corporation (NYSE:XOM), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA) 2021/07/14 23:00:55 Stock Equity
Nikola Corporation (NKLA) with the stream of -1.40% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -2.59% in the last hour of Wednesdays trading session. Nikola The post Sector Percentage Losers: Nikola Corporation (NASDAQ:NKLA), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .
Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA) 2021/07/12 22:55:48 Stock Equity
Freeport-McMoRan Inc. (FCX) with the stream of 0.08% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -3.45% in the last hour of Mondays trading session. Freeport-McMoRan The post Traders shouldnt Staggering on this: Freeport-McMoRan Inc. (NYSE:FCX), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .